nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2B6—malignant glioma	0.566	1	CbGaD
Selegiline—CYP1A2—Carmustine—malignant glioma	0.0957	0.57	CbGbCtD
Selegiline—CYP3A4—Temozolomide—malignant glioma	0.0723	0.431	CbGbCtD
Selegiline—Myeloid leukaemia—Temozolomide—malignant glioma	0.00823	0.0534	CcSEcCtD
Selegiline—Abnormal platelets—Temozolomide—malignant glioma	0.00749	0.0486	CcSEcCtD
Selegiline—Platelet disorder—Temozolomide—malignant glioma	0.00595	0.0386	CcSEcCtD
Selegiline—Acute leukaemia—Carmustine—malignant glioma	0.00313	0.0203	CcSEcCtD
Selegiline—Acute leukaemia—Temozolomide—malignant glioma	0.00302	0.0196	CcSEcCtD
Selegiline—Paranoid reaction—Carmustine—malignant glioma	0.0021	0.0136	CcSEcCtD
Selegiline—Personality disorder—Carmustine—malignant glioma	0.00207	0.0134	CcSEcCtD
Selegiline—Cerebral ischaemia—Temozolomide—malignant glioma	0.00179	0.0116	CcSEcCtD
Selegiline—Myasthenia—Carmustine—malignant glioma	0.00142	0.00922	CcSEcCtD
Selegiline—Encephalopathy—Carmustine—malignant glioma	0.00139	0.00903	CcSEcCtD
Selegiline—Aphasia—Carmustine—malignant glioma	0.00138	0.00894	CcSEcCtD
Selegiline—Parosmia—Temozolomide—malignant glioma	0.00133	0.00864	CcSEcCtD
Selegiline—Tooth disorder—Temozolomide—malignant glioma	0.00133	0.00864	CcSEcCtD
Selegiline—Aphasia—Temozolomide—malignant glioma	0.00133	0.00864	CcSEcCtD
Selegiline—Hypokinesia—Carmustine—malignant glioma	0.00132	0.00859	CcSEcCtD
Selegiline—Paranoia—Carmustine—malignant glioma	0.00131	0.00851	CcSEcCtD
Selegiline—Myopathy—Temozolomide—malignant glioma	0.00123	0.00799	CcSEcCtD
Selegiline—Apathy—Temozolomide—malignant glioma	0.00121	0.00784	CcSEcCtD
Selegiline—Flat affect—Temozolomide—malignant glioma	0.0012	0.00777	CcSEcCtD
Selegiline—Scotoma—Carmustine—malignant glioma	0.00118	0.00764	CcSEcCtD
Selegiline—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00117	0.00757	CcSEcCtD
Selegiline—Menorrhagia—Temozolomide—malignant glioma	0.00117	0.00757	CcSEcCtD
Selegiline—Herpes zoster—Temozolomide—malignant glioma	0.00115	0.00744	CcSEcCtD
Selegiline—Scotoma—Temozolomide—malignant glioma	0.00114	0.00738	CcSEcCtD
Selegiline—Otitis media—Temozolomide—malignant glioma	0.00111	0.0072	CcSEcCtD
Selegiline—Hyperaesthesia—Temozolomide—malignant glioma	0.0011	0.00714	CcSEcCtD
Selegiline—Memory impairment—Temozolomide—malignant glioma	0.0011	0.00714	CcSEcCtD
Selegiline—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00105	0.00681	CcSEcCtD
Selegiline—Petechiae—Temozolomide—malignant glioma	0.00105	0.00681	CcSEcCtD
Selegiline—Accidental injury—Carmustine—malignant glioma	0.00101	0.00655	CcSEcCtD
Selegiline—Breast pain—Temozolomide—malignant glioma	0.000989	0.00642	CcSEcCtD
Selegiline—Amenorrhoea—Temozolomide—malignant glioma	0.000982	0.00638	CcSEcCtD
Selegiline—Thinking abnormal—Carmustine—malignant glioma	0.000976	0.00633	CcSEcCtD
Selegiline—Pseudoephedrine—IL2—malignant glioma	0.000966	0.147	CrCbGaD
Selegiline—Viral infection—Temozolomide—malignant glioma	0.000956	0.0062	CcSEcCtD
Selegiline—Leukocytosis—Carmustine—malignant glioma	0.000951	0.00617	CcSEcCtD
Selegiline—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.000949	0.00616	CcSEcCtD
Selegiline—Herpes simplex—Temozolomide—malignant glioma	0.000937	0.00608	CcSEcCtD
Selegiline—Gait disturbance—Carmustine—malignant glioma	0.000915	0.00594	CcSEcCtD
Selegiline—Coordination abnormal—Carmustine—malignant glioma	0.00091	0.0059	CcSEcCtD
Selegiline—Neck pain—Carmustine—malignant glioma	0.000904	0.00587	CcSEcCtD
Selegiline—Gait disturbance—Temozolomide—malignant glioma	0.000884	0.00574	CcSEcCtD
Selegiline—Coordination abnormal—Temozolomide—malignant glioma	0.000879	0.00571	CcSEcCtD
Selegiline—Vaginal inflammation—Temozolomide—malignant glioma	0.000863	0.0056	CcSEcCtD
Selegiline—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000863	0.0056	CcSEcCtD
Selegiline—Urinary incontinence—Carmustine—malignant glioma	0.000863	0.0056	CcSEcCtD
Selegiline—Benzphetamine—POR—malignant glioma	0.000859	0.131	CrCbGaD
Selegiline—Candida infection—Carmustine—malignant glioma	0.000853	0.00554	CcSEcCtD
Selegiline—Neuropathy—Carmustine—malignant glioma	0.000839	0.00544	CcSEcCtD
Selegiline—Urinary incontinence—Temozolomide—malignant glioma	0.000834	0.00541	CcSEcCtD
Selegiline—Candida infection—Temozolomide—malignant glioma	0.000824	0.00535	CcSEcCtD
Selegiline—Coma—Carmustine—malignant glioma	0.000816	0.0053	CcSEcCtD
Selegiline—Vaginal infection—Temozolomide—malignant glioma	0.000815	0.00529	CcSEcCtD
Selegiline—Neuropathy—Temozolomide—malignant glioma	0.00081	0.00526	CcSEcCtD
Selegiline—Neoplasm—Carmustine—malignant glioma	0.000808	0.00524	CcSEcCtD
Selegiline—Dry eye—Temozolomide—malignant glioma	0.000797	0.00518	CcSEcCtD
Selegiline—Diethylpropion—SLC6A3—malignant glioma	0.000781	0.119	CrCbGaD
Selegiline—Neoplasm—Temozolomide—malignant glioma	0.00078	0.00507	CcSEcCtD
Selegiline—Abnormal vision—Carmustine—malignant glioma	0.000779	0.00506	CcSEcCtD
Selegiline—Mental disability—Carmustine—malignant glioma	0.000775	0.00503	CcSEcCtD
Selegiline—Abnormal vision—Temozolomide—malignant glioma	0.000753	0.00489	CcSEcCtD
Selegiline—Mental disability—Temozolomide—malignant glioma	0.000749	0.00486	CcSEcCtD
Selegiline—Diabetes mellitus—Carmustine—malignant glioma	0.000746	0.00484	CcSEcCtD
Selegiline—Ear pain—Temozolomide—malignant glioma	0.000734	0.00477	CcSEcCtD
Selegiline—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00072	0.00468	CcSEcCtD
Selegiline—Eye pain—Carmustine—malignant glioma	0.000718	0.00466	CcSEcCtD
Selegiline—Gastroenteritis—Temozolomide—malignant glioma	0.000707	0.00459	CcSEcCtD
Selegiline—Injury—Carmustine—malignant glioma	0.000705	0.00458	CcSEcCtD
Selegiline—Deafness—Temozolomide—malignant glioma	0.0007	0.00455	CcSEcCtD
Selegiline—Eye pain—Temozolomide—malignant glioma	0.000694	0.00451	CcSEcCtD
Selegiline—Amnesia—Carmustine—malignant glioma	0.00069	0.00448	CcSEcCtD
Selegiline—Amnesia—Temozolomide—malignant glioma	0.000667	0.00433	CcSEcCtD
Selegiline—Thirst—Temozolomide—malignant glioma	0.000658	0.00427	CcSEcCtD
Selegiline—Hyponatraemia—Carmustine—malignant glioma	0.000651	0.00423	CcSEcCtD
Selegiline—Diplopia—Carmustine—malignant glioma	0.000648	0.00421	CcSEcCtD
Selegiline—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000648	0.00421	CcSEcCtD
Selegiline—Diplopia—Temozolomide—malignant glioma	0.000627	0.00407	CcSEcCtD
Selegiline—Face oedema—Carmustine—malignant glioma	0.000626	0.00406	CcSEcCtD
Selegiline—Affect lability—Temozolomide—malignant glioma	0.000617	0.004	CcSEcCtD
Selegiline—Ataxia—Carmustine—malignant glioma	0.00061	0.00396	CcSEcCtD
Selegiline—Face oedema—Temozolomide—malignant glioma	0.000605	0.00393	CcSEcCtD
Selegiline—Liver function test abnormal—Carmustine—malignant glioma	0.000599	0.00389	CcSEcCtD
Selegiline—Mood swings—Temozolomide—malignant glioma	0.000594	0.00385	CcSEcCtD
Selegiline—Lisdexamfetamine—SLC6A3—malignant glioma	0.000592	0.09	CrCbGaD
Selegiline—Hypokalaemia—Carmustine—malignant glioma	0.00059	0.00383	CcSEcCtD
Selegiline—Ataxia—Temozolomide—malignant glioma	0.000589	0.00382	CcSEcCtD
Selegiline—Dehydration—Temozolomide—malignant glioma	0.000583	0.00378	CcSEcCtD
Selegiline—Dry skin—Temozolomide—malignant glioma	0.000574	0.00373	CcSEcCtD
Selegiline—Muscular weakness—Carmustine—malignant glioma	0.000572	0.00371	CcSEcCtD
Selegiline—Hypokalaemia—Temozolomide—malignant glioma	0.00057	0.0037	CcSEcCtD
Selegiline—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000564	0.00366	CcSEcCtD
Selegiline—Dysphagia—Carmustine—malignant glioma	0.00056	0.00364	CcSEcCtD
Selegiline—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000553	0.00359	CcSEcCtD
Selegiline—Muscular weakness—Temozolomide—malignant glioma	0.000553	0.00359	CcSEcCtD
Selegiline—Dysphagia—Temozolomide—malignant glioma	0.000542	0.00352	CcSEcCtD
Selegiline—Sweating increased—Temozolomide—malignant glioma	0.000528	0.00342	CcSEcCtD
Selegiline—Bronchitis—Temozolomide—malignant glioma	0.000521	0.00338	CcSEcCtD
Selegiline—Dysuria—Temozolomide—malignant glioma	0.000506	0.00329	CcSEcCtD
Selegiline—Hyperglycaemia—Carmustine—malignant glioma	0.000506	0.00328	CcSEcCtD
Selegiline—Pneumonia—Carmustine—malignant glioma	0.000503	0.00326	CcSEcCtD
Selegiline—Pollakiuria—Temozolomide—malignant glioma	0.0005	0.00325	CcSEcCtD
Selegiline—Erectile dysfunction—Temozolomide—malignant glioma	0.000499	0.00324	CcSEcCtD
Selegiline—Depression—Carmustine—malignant glioma	0.000498	0.00323	CcSEcCtD
Selegiline—Photosensitivity reaction—Temozolomide—malignant glioma	0.000494	0.00321	CcSEcCtD
Selegiline—Weight increased—Temozolomide—malignant glioma	0.000493	0.0032	CcSEcCtD
Selegiline—Weight decreased—Temozolomide—malignant glioma	0.00049	0.00318	CcSEcCtD
Selegiline—Neuropathy peripheral—Carmustine—malignant glioma	0.00049	0.00318	CcSEcCtD
Selegiline—Hyperglycaemia—Temozolomide—malignant glioma	0.000489	0.00317	CcSEcCtD
Selegiline—Stomatitis—Carmustine—malignant glioma	0.000487	0.00316	CcSEcCtD
Selegiline—Urinary tract infection—Carmustine—malignant glioma	0.000486	0.00315	CcSEcCtD
Selegiline—Pneumonia—Temozolomide—malignant glioma	0.000486	0.00315	CcSEcCtD
Selegiline—Depression—Temozolomide—malignant glioma	0.000482	0.00313	CcSEcCtD
Selegiline—Neuropathy peripheral—Temozolomide—malignant glioma	0.000473	0.00307	CcSEcCtD
Selegiline—Stomatitis—Temozolomide—malignant glioma	0.000471	0.00306	CcSEcCtD
Selegiline—Urinary tract infection—Temozolomide—malignant glioma	0.000469	0.00305	CcSEcCtD
Selegiline—Hepatobiliary disease—Temozolomide—malignant glioma	0.000457	0.00296	CcSEcCtD
Selegiline—Sinusitis—Temozolomide—malignant glioma	0.000453	0.00294	CcSEcCtD
Selegiline—Hypoaesthesia—Carmustine—malignant glioma	0.000446	0.0029	CcSEcCtD
Selegiline—Hallucination—Carmustine—malignant glioma	0.000446	0.0029	CcSEcCtD
Selegiline—Ephedrine—BCHE—malignant glioma	0.000443	0.0674	CrCbGaD
Selegiline—Oedema peripheral—Carmustine—malignant glioma	0.000442	0.00287	CcSEcCtD
Selegiline—Hepatitis—Temozolomide—malignant glioma	0.000434	0.00281	CcSEcCtD
Selegiline—Visual impairment—Carmustine—malignant glioma	0.000432	0.00281	CcSEcCtD
Selegiline—Hypoaesthesia—Temozolomide—malignant glioma	0.000431	0.0028	CcSEcCtD
Selegiline—Hallucination—Temozolomide—malignant glioma	0.000431	0.0028	CcSEcCtD
Selegiline—Pharyngitis—Temozolomide—malignant glioma	0.00043	0.00279	CcSEcCtD
Selegiline—Urinary tract disorder—Temozolomide—malignant glioma	0.000428	0.00278	CcSEcCtD
Selegiline—Oedema peripheral—Temozolomide—malignant glioma	0.000427	0.00277	CcSEcCtD
Selegiline—Urethral disorder—Temozolomide—malignant glioma	0.000425	0.00276	CcSEcCtD
Selegiline—Benzyl alcohol—CYP2B6—malignant glioma	0.000419	0.0637	CrCbGaD
Selegiline—Visual impairment—Temozolomide—malignant glioma	0.000418	0.00271	CcSEcCtD
Selegiline—Flushing—Carmustine—malignant glioma	0.000416	0.0027	CcSEcCtD
Selegiline—Tinnitus—Temozolomide—malignant glioma	0.000404	0.00262	CcSEcCtD
Selegiline—Flushing—Temozolomide—malignant glioma	0.000402	0.00261	CcSEcCtD
Selegiline—Arrhythmia—Carmustine—malignant glioma	0.000401	0.0026	CcSEcCtD
Selegiline—Alopecia—Carmustine—malignant glioma	0.000396	0.00257	CcSEcCtD
Selegiline—Angiopathy—Temozolomide—malignant glioma	0.000393	0.00255	CcSEcCtD
Selegiline—Mental disorder—Carmustine—malignant glioma	0.000393	0.00255	CcSEcCtD
Selegiline—Malnutrition—Carmustine—malignant glioma	0.000391	0.00253	CcSEcCtD
Selegiline—Erythema—Carmustine—malignant glioma	0.000391	0.00253	CcSEcCtD
Selegiline—Chills—Temozolomide—malignant glioma	0.000389	0.00252	CcSEcCtD
Selegiline—Alopecia—Temozolomide—malignant glioma	0.000383	0.00249	CcSEcCtD
Selegiline—Mental disorder—Temozolomide—malignant glioma	0.00038	0.00247	CcSEcCtD
Selegiline—Back pain—Carmustine—malignant glioma	0.000378	0.00245	CcSEcCtD
Selegiline—Erythema—Temozolomide—malignant glioma	0.000377	0.00245	CcSEcCtD
Selegiline—Malnutrition—Temozolomide—malignant glioma	0.000377	0.00245	CcSEcCtD
Selegiline—Phentermine—SLC6A3—malignant glioma	0.00037	0.0563	CrCbGaD
Selegiline—Dysgeusia—Temozolomide—malignant glioma	0.00037	0.0024	CcSEcCtD
Selegiline—Vision blurred—Carmustine—malignant glioma	0.000368	0.00239	CcSEcCtD
Selegiline—Tremor—Carmustine—malignant glioma	0.000366	0.00237	CcSEcCtD
Selegiline—Back pain—Temozolomide—malignant glioma	0.000365	0.00237	CcSEcCtD
Selegiline—Anaemia—Carmustine—malignant glioma	0.000361	0.00234	CcSEcCtD
Selegiline—Agitation—Carmustine—malignant glioma	0.000359	0.00233	CcSEcCtD
Selegiline—Vision blurred—Temozolomide—malignant glioma	0.000356	0.00231	CcSEcCtD
Selegiline—Tremor—Temozolomide—malignant glioma	0.000354	0.00229	CcSEcCtD
Selegiline—Dextroamphetamine—SLC6A3—malignant glioma	0.000353	0.0537	CrCbGaD
Selegiline—Pseudoephedrine—SLC6A3—malignant glioma	0.000351	0.0534	CrCbGaD
Selegiline—Ill-defined disorder—Temozolomide—malignant glioma	0.00035	0.00227	CcSEcCtD
Selegiline—Leukopenia—Carmustine—malignant glioma	0.00035	0.00227	CcSEcCtD
Selegiline—Anaemia—Temozolomide—malignant glioma	0.000349	0.00226	CcSEcCtD
Selegiline—Agitation—Temozolomide—malignant glioma	0.000347	0.00225	CcSEcCtD
Selegiline—Malaise—Temozolomide—malignant glioma	0.00034	0.00221	CcSEcCtD
Selegiline—Vertigo—Temozolomide—malignant glioma	0.000339	0.0022	CcSEcCtD
Selegiline—Convulsion—Carmustine—malignant glioma	0.000338	0.0022	CcSEcCtD
Selegiline—Leukopenia—Temozolomide—malignant glioma	0.000338	0.00219	CcSEcCtD
Selegiline—Hypertension—Carmustine—malignant glioma	0.000337	0.00219	CcSEcCtD
Selegiline—Palpitations—Temozolomide—malignant glioma	0.000333	0.00216	CcSEcCtD
Selegiline—Chest pain—Carmustine—malignant glioma	0.000332	0.00216	CcSEcCtD
Selegiline—Myalgia—Carmustine—malignant glioma	0.000332	0.00216	CcSEcCtD
Selegiline—Anxiety—Carmustine—malignant glioma	0.000331	0.00215	CcSEcCtD
Selegiline—Cough—Temozolomide—malignant glioma	0.000329	0.00214	CcSEcCtD
Selegiline—Convulsion—Temozolomide—malignant glioma	0.000327	0.00212	CcSEcCtD
Selegiline—Pseudoephedrine—TNF—malignant glioma	0.000326	0.0496	CrCbGaD
Selegiline—Hypertension—Temozolomide—malignant glioma	0.000326	0.00211	CcSEcCtD
Selegiline—Confusional state—Carmustine—malignant glioma	0.000321	0.00209	CcSEcCtD
Selegiline—Myalgia—Temozolomide—malignant glioma	0.000321	0.00209	CcSEcCtD
Selegiline—Arthralgia—Temozolomide—malignant glioma	0.000321	0.00209	CcSEcCtD
Selegiline—Anxiety—Temozolomide—malignant glioma	0.00032	0.00208	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000319	0.00207	CcSEcCtD
Selegiline—Oedema—Carmustine—malignant glioma	0.000319	0.00207	CcSEcCtD
Selegiline—Discomfort—Temozolomide—malignant glioma	0.000317	0.00206	CcSEcCtD
Selegiline—Infection—Carmustine—malignant glioma	0.000317	0.00206	CcSEcCtD
Selegiline—Dry mouth—Temozolomide—malignant glioma	0.000314	0.00204	CcSEcCtD
Selegiline—Thrombocytopenia—Carmustine—malignant glioma	0.000312	0.00203	CcSEcCtD
Selegiline—Tachycardia—Carmustine—malignant glioma	0.000311	0.00202	CcSEcCtD
Selegiline—Confusional state—Temozolomide—malignant glioma	0.000311	0.00202	CcSEcCtD
Selegiline—Oedema—Temozolomide—malignant glioma	0.000308	0.002	CcSEcCtD
Selegiline—Benzphetamine—CYP2B6—malignant glioma	0.000307	0.0467	CrCbGaD
Selegiline—Infection—Temozolomide—malignant glioma	0.000306	0.00199	CcSEcCtD
Selegiline—Anorexia—Carmustine—malignant glioma	0.000304	0.00197	CcSEcCtD
Selegiline—Nervous system disorder—Temozolomide—malignant glioma	0.000302	0.00196	CcSEcCtD
Selegiline—Thrombocytopenia—Temozolomide—malignant glioma	0.000302	0.00196	CcSEcCtD
Selegiline—Skin disorder—Temozolomide—malignant glioma	0.000299	0.00194	CcSEcCtD
Selegiline—Hypotension—Carmustine—malignant glioma	0.000298	0.00193	CcSEcCtD
Selegiline—Hyperhidrosis—Temozolomide—malignant glioma	0.000298	0.00193	CcSEcCtD
Selegiline—Anorexia—Temozolomide—malignant glioma	0.000294	0.00191	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00029	0.00188	CcSEcCtD
Selegiline—Insomnia—Carmustine—malignant glioma	0.000288	0.00187	CcSEcCtD
Selegiline—Paraesthesia—Carmustine—malignant glioma	0.000286	0.00186	CcSEcCtD
Selegiline—Amphetamine—SLC6A3—malignant glioma	0.000285	0.0433	CrCbGaD
Selegiline—Dyspnoea—Carmustine—malignant glioma	0.000284	0.00184	CcSEcCtD
Selegiline—Somnolence—Carmustine—malignant glioma	0.000283	0.00184	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000281	0.00182	CcSEcCtD
Selegiline—Insomnia—Temozolomide—malignant glioma	0.000279	0.00181	CcSEcCtD
Selegiline—Decreased appetite—Carmustine—malignant glioma	0.000277	0.0018	CcSEcCtD
Selegiline—Paraesthesia—Temozolomide—malignant glioma	0.000277	0.0018	CcSEcCtD
Selegiline—Gastrointestinal disorder—Carmustine—malignant glioma	0.000275	0.00179	CcSEcCtD
Selegiline—Dyspnoea—Temozolomide—malignant glioma	0.000275	0.00178	CcSEcCtD
Selegiline—Somnolence—Temozolomide—malignant glioma	0.000274	0.00178	CcSEcCtD
Selegiline—Pain—Carmustine—malignant glioma	0.000273	0.00177	CcSEcCtD
Selegiline—Constipation—Carmustine—malignant glioma	0.000273	0.00177	CcSEcCtD
Selegiline—Dyspepsia—Temozolomide—malignant glioma	0.000271	0.00176	CcSEcCtD
Selegiline—Decreased appetite—Temozolomide—malignant glioma	0.000268	0.00174	CcSEcCtD
Selegiline—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000266	0.00173	CcSEcCtD
Selegiline—Fatigue—Temozolomide—malignant glioma	0.000266	0.00172	CcSEcCtD
Selegiline—Methamphetamine—SLC6A3—malignant glioma	0.000264	0.0401	CrCbGaD
Selegiline—Pain—Temozolomide—malignant glioma	0.000263	0.00171	CcSEcCtD
Selegiline—Constipation—Temozolomide—malignant glioma	0.000263	0.00171	CcSEcCtD
Selegiline—Feeling abnormal—Carmustine—malignant glioma	0.000263	0.0017	CcSEcCtD
Selegiline—Benzphetamine—SLC6A3—malignant glioma	0.000262	0.0398	CrCbGaD
Selegiline—Gastrointestinal pain—Carmustine—malignant glioma	0.000261	0.00169	CcSEcCtD
Selegiline—Feeling abnormal—Temozolomide—malignant glioma	0.000254	0.00165	CcSEcCtD
Selegiline—Abdominal pain—Carmustine—malignant glioma	0.000252	0.00164	CcSEcCtD
Selegiline—Body temperature increased—Carmustine—malignant glioma	0.000252	0.00164	CcSEcCtD
Selegiline—Gastrointestinal pain—Temozolomide—malignant glioma	0.000252	0.00163	CcSEcCtD
Selegiline—Urticaria—Temozolomide—malignant glioma	0.000245	0.00159	CcSEcCtD
Selegiline—Body temperature increased—Temozolomide—malignant glioma	0.000243	0.00158	CcSEcCtD
Selegiline—Abdominal pain—Temozolomide—malignant glioma	0.000243	0.00158	CcSEcCtD
Selegiline—Hypersensitivity—Carmustine—malignant glioma	0.000235	0.00152	CcSEcCtD
Selegiline—Asthenia—Carmustine—malignant glioma	0.000229	0.00148	CcSEcCtD
Selegiline—Hypersensitivity—Temozolomide—malignant glioma	0.000227	0.00147	CcSEcCtD
Selegiline—Asthenia—Temozolomide—malignant glioma	0.000221	0.00143	CcSEcCtD
Selegiline—Diarrhoea—Carmustine—malignant glioma	0.000218	0.00142	CcSEcCtD
Selegiline—Pruritus—Temozolomide—malignant glioma	0.000218	0.00141	CcSEcCtD
Selegiline—Dizziness—Carmustine—malignant glioma	0.000211	0.00137	CcSEcCtD
Selegiline—Diarrhoea—Temozolomide—malignant glioma	0.000211	0.00137	CcSEcCtD
Selegiline—Dizziness—Temozolomide—malignant glioma	0.000204	0.00132	CcSEcCtD
Selegiline—Vomiting—Carmustine—malignant glioma	0.000203	0.00132	CcSEcCtD
Selegiline—Rash—Carmustine—malignant glioma	0.000201	0.0013	CcSEcCtD
Selegiline—Dermatitis—Carmustine—malignant glioma	0.000201	0.0013	CcSEcCtD
Selegiline—Headache—Carmustine—malignant glioma	0.0002	0.0013	CcSEcCtD
Selegiline—Vomiting—Temozolomide—malignant glioma	0.000196	0.00127	CcSEcCtD
Selegiline—Rash—Temozolomide—malignant glioma	0.000194	0.00126	CcSEcCtD
Selegiline—Dermatitis—Temozolomide—malignant glioma	0.000194	0.00126	CcSEcCtD
Selegiline—Headache—Temozolomide—malignant glioma	0.000193	0.00125	CcSEcCtD
Selegiline—Nausea—Carmustine—malignant glioma	0.000189	0.00123	CcSEcCtD
Selegiline—Nausea—Temozolomide—malignant glioma	0.000183	0.00119	CcSEcCtD
Selegiline—MAOB—embryo—malignant glioma	0.000118	0.0498	CbGeAlD
Selegiline—MAOB—brainstem—malignant glioma	0.000108	0.0457	CbGeAlD
Selegiline—MAOA—embryo—malignant glioma	0.000101	0.0425	CbGeAlD
Selegiline—MAOB—telencephalon—malignant glioma	9.58e-05	0.0405	CbGeAlD
Selegiline—MAOA—brainstem—malignant glioma	9.21e-05	0.039	CbGeAlD
Selegiline—MAOA—retina—malignant glioma	8.89e-05	0.0376	CbGeAlD
Selegiline—MAOA—telencephalon—malignant glioma	8.18e-05	0.0346	CbGeAlD
Selegiline—MAOB—medulla oblongata—malignant glioma	7.53e-05	0.0319	CbGeAlD
Selegiline—CYP2A6—cerebellum—malignant glioma	7.22e-05	0.0305	CbGeAlD
Selegiline—ABCB1—blood vessel—malignant glioma	7.21e-05	0.0305	CbGeAlD
Selegiline—MAOB—midbrain—malignant glioma	6.88e-05	0.0291	CbGeAlD
Selegiline—MAOB—spinal cord—malignant glioma	6.71e-05	0.0284	CbGeAlD
Selegiline—MAOA—medulla oblongata—malignant glioma	6.42e-05	0.0272	CbGeAlD
Selegiline—CYP2E1—telencephalon—malignant glioma	6.14e-05	0.026	CbGeAlD
Selegiline—MAOA—midbrain—malignant glioma	5.87e-05	0.0248	CbGeAlD
Selegiline—CYP2A6—brain—malignant glioma	5.86e-05	0.0248	CbGeAlD
Selegiline—MAOA—spinal cord—malignant glioma	5.73e-05	0.0242	CbGeAlD
Selegiline—CYP2D6—brainstem—malignant glioma	5.48e-05	0.0232	CbGeAlD
Selegiline—MAOB—central nervous system—malignant glioma	5.45e-05	0.023	CbGeAlD
Selegiline—MAOB—cerebellum—malignant glioma	5.32e-05	0.0225	CbGeAlD
Selegiline—CYP2D6—telencephalon—malignant glioma	4.86e-05	0.0206	CbGeAlD
Selegiline—CYP2E1—medulla oblongata—malignant glioma	4.82e-05	0.0204	CbGeAlD
Selegiline—MAOA—central nervous system—malignant glioma	4.65e-05	0.0197	CbGeAlD
Selegiline—MAOA—cerebellum—malignant glioma	4.54e-05	0.0192	CbGeAlD
Selegiline—MAOB—brain—malignant glioma	4.32e-05	0.0183	CbGeAlD
Selegiline—CYP2E1—spinal cord—malignant glioma	4.3e-05	0.0182	CbGeAlD
Selegiline—ABCB1—embryo—malignant glioma	4.3e-05	0.0182	CbGeAlD
Selegiline—ABCB1—retina—malignant glioma	3.8e-05	0.0161	CbGeAlD
Selegiline—CYP2B6—central nervous system—malignant glioma	3.72e-05	0.0157	CbGeAlD
Selegiline—MAOA—brain—malignant glioma	3.69e-05	0.0156	CbGeAlD
Selegiline—ABCB1—telencephalon—malignant glioma	3.5e-05	0.0148	CbGeAlD
Selegiline—CYP2E1—central nervous system—malignant glioma	3.49e-05	0.0148	CbGeAlD
Selegiline—CYP2E1—cerebellum—malignant glioma	3.41e-05	0.0144	CbGeAlD
Selegiline—CYP2C8—brain—malignant glioma	3.29e-05	0.0139	CbGeAlD
Selegiline—CYP2B6—brain—malignant glioma	2.95e-05	0.0125	CbGeAlD
Selegiline—CYP3A4—central nervous system—malignant glioma	2.81e-05	0.0119	CbGeAlD
Selegiline—CYP2E1—brain—malignant glioma	2.77e-05	0.0117	CbGeAlD
Selegiline—CYP2D6—central nervous system—malignant glioma	2.76e-05	0.0117	CbGeAlD
Selegiline—ABCB1—medulla oblongata—malignant glioma	2.75e-05	0.0116	CbGeAlD
Selegiline—CYP2D6—cerebellum—malignant glioma	2.7e-05	0.0114	CbGeAlD
Selegiline—ABCB1—midbrain—malignant glioma	2.51e-05	0.0106	CbGeAlD
Selegiline—ABCB1—spinal cord—malignant glioma	2.45e-05	0.0104	CbGeAlD
Selegiline—CYP2D6—brain—malignant glioma	2.19e-05	0.00927	CbGeAlD
Selegiline—ABCB1—central nervous system—malignant glioma	1.99e-05	0.0084	CbGeAlD
Selegiline—ABCB1—cerebellum—malignant glioma	1.94e-05	0.00821	CbGeAlD
Selegiline—CYP2A6—Metabolism—BCHE—malignant glioma	1.73e-05	0.000168	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.72e-05	0.000167	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CAT—malignant glioma	1.72e-05	0.000167	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—COX8A—malignant glioma	1.71e-05	0.000166	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—SPHK1—malignant glioma	1.71e-05	0.000166	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—SLC5A5—malignant glioma	1.7e-05	0.000166	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CD—malignant glioma	1.69e-05	0.000164	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—IDH2—malignant glioma	1.69e-05	0.000164	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP2B6—malignant glioma	1.68e-05	0.000163	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP2C18—malignant glioma	1.67e-05	0.000163	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—IDH2—malignant glioma	1.67e-05	0.000162	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.65e-05	0.00016	CbGpPWpGaD
Selegiline—MAOA—Metabolism—NCOR1—malignant glioma	1.63e-05	0.000158	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.61e-05	0.000157	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTT1—malignant glioma	1.6e-05	0.000155	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.58e-05	0.000154	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.58e-05	0.000153	CbGpPWpGaD
Selegiline—ABCB1—brain—malignant glioma	1.58e-05	0.00667	CbGeAlD
Selegiline—CYP2C19—Metabolism—IDH1—malignant glioma	1.58e-05	0.000153	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.58e-05	0.000153	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.57e-05	0.000153	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTT1—malignant glioma	1.57e-05	0.000152	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—IDH1—malignant glioma	1.54e-05	0.000149	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.54e-05	0.000149	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.52e-05	0.000148	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—SPHK1—malignant glioma	1.52e-05	0.000148	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTGS1—malignant glioma	1.5e-05	0.000146	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.49e-05	0.000145	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—SPHK1—malignant glioma	1.49e-05	0.000145	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CB—malignant glioma	1.47e-05	0.000143	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTGS1—malignant glioma	1.47e-05	0.000143	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PTGS2—malignant glioma	1.46e-05	0.000142	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP2C18—malignant glioma	1.46e-05	0.000142	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ASMT—malignant glioma	1.45e-05	0.000141	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—IDH1—malignant glioma	1.45e-05	0.000141	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.44e-05	0.00014	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—IDH1—malignant glioma	1.44e-05	0.00014	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—IDH2—malignant glioma	1.43e-05	0.000139	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.41e-05	0.000137	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—SPHK1—malignant glioma	1.4e-05	0.000136	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.4e-05	0.000136	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—BCHE—malignant glioma	1.39e-05	0.000135	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—SPHK1—malignant glioma	1.39e-05	0.000135	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.39e-05	0.000135	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.38e-05	0.000134	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.37e-05	0.000133	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GSTP1—malignant glioma	1.37e-05	0.000133	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—BCAN—malignant glioma	1.37e-05	0.000133	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—BCHE—malignant glioma	1.36e-05	0.000133	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.36e-05	0.000132	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.35e-05	0.000132	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTT1—malignant glioma	1.35e-05	0.000131	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—SLC5A5—malignant glioma	1.35e-05	0.000131	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.35e-05	0.000131	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.34e-05	0.00013	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CAT—malignant glioma	1.34e-05	0.00013	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CAV1—malignant glioma	1.33e-05	0.000129	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.28e-05	0.000125	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.28e-05	0.000125	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PTEN—malignant glioma	1.27e-05	0.000124	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTGS1—malignant glioma	1.27e-05	0.000123	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.26e-05	0.000123	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—NCOR1—malignant glioma	1.26e-05	0.000123	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.24e-05	0.00012	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—IDH1—malignant glioma	1.23e-05	0.000119	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTT1—malignant glioma	1.21e-05	0.000117	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CG—malignant glioma	1.21e-05	0.000117	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SPHK1—malignant glioma	1.19e-05	0.000115	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTT1—malignant glioma	1.18e-05	0.000115	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—BCHE—malignant glioma	1.18e-05	0.000115	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.17e-05	0.000114	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PPARG—malignant glioma	1.16e-05	0.000113	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.16e-05	0.000113	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.16e-05	0.000113	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.14e-05	0.000111	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTGS1—malignant glioma	1.13e-05	0.00011	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.13e-05	0.00011	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.13e-05	0.00011	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTT1—malignant glioma	1.11e-05	0.000108	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTP1—malignant glioma	1.11e-05	0.000108	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTGS1—malignant glioma	1.1e-05	0.000107	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—IDH2—malignant glioma	1.1e-05	0.000107	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTT1—malignant glioma	1.1e-05	0.000107	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.1e-05	0.000107	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.1e-05	0.000107	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.09e-05	0.000106	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTP1—malignant glioma	1.09e-05	0.000105	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CAT—malignant glioma	1.08e-05	0.000105	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CD—malignant glioma	1.06e-05	0.000103	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CAT—malignant glioma	1.06e-05	0.000103	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—BCHE—malignant glioma	1.05e-05	0.000102	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTGS1—malignant glioma	1.04e-05	0.000101	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.04e-05	0.000101	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.04e-05	0.000101	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTGS1—malignant glioma	1.03e-05	0.0001	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CAV1—malignant glioma	1.03e-05	9.99e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.03e-05	9.99e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—BCHE—malignant glioma	1.03e-05	9.98e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—NCOR1—malignant glioma	1.02e-05	9.89e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—SLC5A5—malignant glioma	1.01e-05	9.86e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1e-05	9.71e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—NCOR1—malignant glioma	9.97e-06	9.69e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.83e-06	9.55e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.74e-06	9.46e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—BCHE—malignant glioma	9.68e-06	9.4e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.65e-06	9.37e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—BCHE—malignant glioma	9.59e-06	9.32e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—SLC5A5—malignant glioma	9.56e-06	9.29e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.52e-06	9.25e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—SLC5A5—malignant glioma	9.48e-06	9.21e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—IDH1—malignant glioma	9.47e-06	9.2e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTT1—malignant glioma	9.41e-06	9.14e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTP1—malignant glioma	9.38e-06	9.11e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CG—malignant glioma	9.37e-06	9.1e-05	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	9.34e-06	9.08e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CB—malignant glioma	9.25e-06	8.98e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SPHK1—malignant glioma	9.17e-06	8.91e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTGS2—malignant glioma	9.16e-06	8.9e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CAT—malignant glioma	9.13e-06	8.87e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PPARG—malignant glioma	9.04e-06	8.79e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CA—malignant glioma	8.98e-06	8.73e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.98e-06	8.73e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.96e-06	8.71e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.88e-06	8.63e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTGS1—malignant glioma	8.82e-06	8.57e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.79e-06	8.54e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NCOR1—malignant glioma	8.62e-06	8.37e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.49e-06	8.25e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTP1—malignant glioma	8.37e-06	8.13e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CAV1—malignant glioma	8.3e-06	8.06e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CD—malignant glioma	8.24e-06	8e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—BCHE—malignant glioma	8.2e-06	7.97e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTP1—malignant glioma	8.17e-06	7.94e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CAT—malignant glioma	8.15e-06	7.92e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CAV1—malignant glioma	8.13e-06	7.9e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SLC5A5—malignant glioma	8.1e-06	7.87e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTEN—malignant glioma	7.99e-06	7.76e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CAT—malignant glioma	7.95e-06	7.73e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.74e-06	7.52e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTP1—malignant glioma	7.7e-06	7.48e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NCOR1—malignant glioma	7.69e-06	7.47e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.66e-06	7.44e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTP1—malignant glioma	7.63e-06	7.42e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.59e-06	7.37e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CG—malignant glioma	7.56e-06	7.34e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NCOR1—malignant glioma	7.51e-06	7.3e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CAT—malignant glioma	7.49e-06	7.28e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CAT—malignant glioma	7.43e-06	7.22e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CG—malignant glioma	7.4e-06	7.19e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—AKT1—malignant glioma	7.34e-06	7.13e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PPARG—malignant glioma	7.3e-06	7.09e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTT1—malignant glioma	7.26e-06	7.06e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CB—malignant glioma	7.18e-06	6.98e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PPARG—malignant glioma	7.15e-06	6.94e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTGS2—malignant glioma	7.11e-06	6.91e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NCOR1—malignant glioma	7.08e-06	6.88e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CAV1—malignant glioma	7.03e-06	6.83e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NCOR1—malignant glioma	7.02e-06	6.82e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS1—malignant glioma	6.81e-06	6.61e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.71e-06	6.52e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CD—malignant glioma	6.65e-06	6.46e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.62e-06	6.43e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTP1—malignant glioma	6.52e-06	6.34e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CD—malignant glioma	6.51e-06	6.32e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CG—malignant glioma	6.4e-06	6.22e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CAT—malignant glioma	6.35e-06	6.17e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—BCHE—malignant glioma	6.33e-06	6.15e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CAV1—malignant glioma	6.27e-06	6.09e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.25e-06	6.07e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTEN—malignant glioma	6.2e-06	6.03e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PPARG—malignant glioma	6.18e-06	6e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CAV1—malignant glioma	6.12e-06	5.95e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NCOR1—malignant glioma	5.99e-06	5.82e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.99e-06	5.82e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.79e-06	5.63e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CAV1—malignant glioma	5.77e-06	5.6e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTGS2—malignant glioma	5.74e-06	5.58e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CAV1—malignant glioma	5.72e-06	5.56e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.71e-06	5.55e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CB—malignant glioma	5.67e-06	5.51e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CA—malignant glioma	5.64e-06	5.48e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CD—malignant glioma	5.63e-06	5.47e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTGS2—malignant glioma	5.62e-06	5.46e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CG—malignant glioma	5.58e-06	5.42e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PPARG—malignant glioma	5.51e-06	5.36e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.46e-06	5.31e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PPARG—malignant glioma	5.38e-06	5.23e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.25e-06	5.1e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.21e-06	5.06e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PPARG—malignant glioma	5.07e-06	4.93e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTP1—malignant glioma	5.03e-06	4.89e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PPARG—malignant glioma	5.03e-06	4.88e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.02e-06	4.88e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTEN—malignant glioma	5.01e-06	4.86e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.9e-06	4.76e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTEN—malignant glioma	4.9e-06	4.76e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CD—malignant glioma	4.9e-06	4.76e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CAT—malignant glioma	4.9e-06	4.76e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CAV1—malignant glioma	4.89e-06	4.75e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTGS2—malignant glioma	4.86e-06	4.72e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.67e-06	4.54e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NCOR1—malignant glioma	4.63e-06	4.49e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.62e-06	4.49e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKT1—malignant glioma	4.61e-06	4.47e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.58e-06	4.45e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.45e-06	4.32e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.38e-06	4.25e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CA—malignant glioma	4.38e-06	4.25e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTGS2—malignant glioma	4.34e-06	4.21e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PPARG—malignant glioma	4.3e-06	4.17e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CB—malignant glioma	4.27e-06	4.15e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTEN—malignant glioma	4.24e-06	4.12e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTGS2—malignant glioma	4.23e-06	4.11e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.03e-06	3.91e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.99e-06	3.88e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTGS2—malignant glioma	3.99e-06	3.88e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTGS2—malignant glioma	3.95e-06	3.84e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.91e-06	3.8e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTEN—malignant glioma	3.78e-06	3.68e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CAV1—malignant glioma	3.77e-06	3.66e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTEN—malignant glioma	3.69e-06	3.59e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKT1—malignant glioma	3.58e-06	3.47e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.53e-06	3.43e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTEN—malignant glioma	3.48e-06	3.38e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CA—malignant glioma	3.46e-06	3.36e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTEN—malignant glioma	3.45e-06	3.35e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.44e-06	3.34e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.41e-06	3.31e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTGS2—malignant glioma	3.38e-06	3.28e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PPARG—malignant glioma	3.32e-06	3.22e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.02e-06	2.93e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.99e-06	2.9e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTEN—malignant glioma	2.95e-06	2.86e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKT1—malignant glioma	2.88e-06	2.8e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKT1—malignant glioma	2.83e-06	2.75e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.67e-06	2.59e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.63e-06	2.56e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS2—malignant glioma	2.61e-06	2.53e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CA—malignant glioma	2.6e-06	2.53e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.45e-06	2.38e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKT1—malignant glioma	2.44e-06	2.37e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.43e-06	2.36e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTEN—malignant glioma	2.27e-06	2.21e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKT1—malignant glioma	2.18e-06	2.12e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKT1—malignant glioma	2.13e-06	2.07e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.08e-06	2.02e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKT1—malignant glioma	2.01e-06	1.95e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKT1—malignant glioma	1.99e-06	1.93e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKT1—malignant glioma	1.7e-06	1.65e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.6e-06	1.56e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKT1—malignant glioma	1.31e-06	1.27e-05	CbGpPWpGaD
